Katherine Augustyn is a prominent inventor based in Menlo Park, California. She has made significant contributions to the field of protease enzymes, holding a total of six patents. Her work focuses on developing innovative enzyme variants that enhance stability and efficiency in various applications.

Latest Patents

Among her latest patents is the development of AprL-clade protease variants and their uses. This patent provides insights into AprL-clade protease enzymes, including variant enzymes and nucleic acids encoding them. The disclosure highlights compositions and methods related to the production and use of these enzymes, particularly an AprL-clade variant subtilisin enzyme that demonstrates improved stability and soil removal compared to its parent enzyme. Another notable patent involves subtilisin variants, which also show enhanced stability and soil removal capabilities compared to reference subtilisins.

Career Highlights

Katherine has worked with notable companies such as Danisco US Inc. and The Procter & Gamble Company. Her experience in these organizations has allowed her to apply her innovative ideas in practical settings, contributing to advancements in enzyme technology.

Collaborations

Katherine has collaborated with esteemed colleagues, including David Aaron Estell and Jian Yao. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of protease enzymes.

Conclusion

Katherine Augustyn's work in protease enzyme innovation showcases her dedication to advancing technology in this area. Her patents reflect her commitment to improving enzyme stability and efficiency, making her a valuable contributor to the scientific community.

This text is generated by artificial intelligence and may not be accurate.